Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cardiac ion channels and transporters represent a diverse group of membrane proteins essential for the generation and propagation of electrical impulses in the heart (StatPearls, 2023). This category includes voltage-gated channels for sodium (e.g., SCN5A), potassium (e.g., KCNH2), and calcium (e.g., CACNA1C), as well as active transporters like the Na+/K+-ATPase and the Na+/Ca2+ exchanger (NCX) (NCBI, 2022). These proteins work in concert to maintain the precise extracellular and intracellular ion concentrations required for stable resting potentials and coordinated action potentials. Dysregulation or genetic mutations in these proteins are primary drivers of cardiac arrhythmias, such as Long QT Syndrome and Brugada Syndrome, and contribute significantly to the pathophysiology of heart failure (PubMed, 2021). Pharmacological intervention targeting these channels is a cornerstone of antiarrhythmic therapy, utilizing drugs like amiodarone, lidocaine, and verapamil to stabilize cardiac rhythm. However, these therapies require careful clinical monitoring due to the high risk of inducing secondary arrhythmias or affecting systemic ion balance (NIH, 2023). The maintenance of general extracellular ion homeostasis is critical, as fluctuations in ions like potassium can profoundly impact the function of these channels and overall cardiac stability.
Modulation of ion flux (sodium, potassium, calcium) across the myocardial cell membrane to regulate electrical excitability, conduction velocity, and mechanical contraction.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cardiac ion channels and transporters (General extracellular ion homeostasis).